Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)
Clinical trial NCT03016143 · COMPLETED
Trial details
- NCT number
- NCT03016143
- Sponsor
- Research Institute for Biological Safety Problems
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2016-11-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.